| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |